These dates are public. The filterable calendar, alerts, exports and AI research are in the app — free account: the next 7 days and 3 companies you track. Plans →
No PDUFA date is tracked for June 2026 yet. Each row shows the drug, company, indication, status and how firm the date is.
No catalysts scheduled
There are no FDA decisions or catalyst events scheduled for June 2026.
View full calendarGet June Catalysts in Your Inbox
Subscribe to receive weekly digests of upcoming PDUFA dates and clinical trial results. Never miss an important FDA decision.
PDUFA dates June 2026: questions
- How many FDA decisions (PDUFA dates) are in June 2026?
- No PDUFA date is tracked for June 2026 as of November 6, 2026.
- What is a PDUFA date?
- The FDA's target date to complete its review of a new drug (NDA) or biologic (BLA) application. On or before it, the FDA approves the application, issues a complete response letter (CRL), or extends the review.
About PDUFA Dates in June 2026
This page tracks all FDA Prescription Drug User Fee Act (PDUFA) dates and biotech catalyst events scheduled for June 2026. PDUFA dates represent FDA's target action dates for reviewing new drug applications (NDAs) and biologics license applications (BLAs).
Biotech investors and traders closely monitor these dates as FDA decisions can significantly impact stock prices. Our calendar includes PDUFA dates, clinical trial results, advisory committee meetings, and other regulatory milestones.
Learn more about PDUFA dates or view the full biotech catalyst calendar.